DIAGNOS Announces Shares for Debt Settlement
BROSSARD, Quebec, June 18, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, announces its intention to settle two (2) arm’s-length demand loans in the aggregate amount of C$125,000 by the issuance of an aggregate number of 625,000 common shares of the Corporation (each a “Share”) at an issue price of C$0,20 per Sh
BROSSARD, Quebec, June 18, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, announces its intention to settle two (2) arm’s-length demand loans in the aggregate amount of C$125,000 by the issuance of an aggregate number of 625,000 common shares of the Corporation (each a “Share”) at an issue price of C$0,20 per Share. The Corporation is proposing to issue the Shares in order to preserve its cash.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.